scholarly journals In Vitro Evidence of Complement Activation in Transplant Associated-Thrombotic Microangiopathy

2017 ◽  
Vol 23 (3) ◽  
pp. S244-S245 ◽  
Author(s):  
Seth Joshua Rotz ◽  
Nathan Luebbering ◽  
Bradley P. Dixon ◽  
Christopher E. Dandoy ◽  
Eleni Gavriilaki ◽  
...  
2017 ◽  
Vol 1 (20) ◽  
pp. 1632-1634 ◽  
Author(s):  
Seth J. Rotz ◽  
Nathan Luebbering ◽  
Bradley P. Dixon ◽  
Eleni Gavriilaki ◽  
Robert A. Brodsky ◽  
...  

Key Points Transplantation-associated thrombotic microangiopathy is associated with complement activation in vitro. This data further supports the use of eculizumab for the treatment of patients with TA-TMA.


1996 ◽  
Vol 76 (05) ◽  
pp. 774-779 ◽  
Author(s):  
John T Brandt ◽  
Carmen J Julius ◽  
Jeanne M Osborne ◽  
Clark L Anderson

SummaryImmune-mediated platelet activation is emerging as an important pathogenic mechanism of thrombosis. In vitro studies have suggested two distinct pathways for immune-mediated platelet activation; one involving clustering of platelet FcyRIIa, the other involving platelet-associated complement activation. HLA-related antibodies have been shown to cause platelet aggregation, but the mechanism has not been clarified. We evaluated the mechanism of platelet aggregation induced by HLA-related antibodies from nine patients. Antibody to platelet FcyRIIa failed to block platelet aggregation with 8/9 samples, indicating that engagement of platelet FcyRIIa is not necessary for the platelet aggregation induced by HLA-related antibodies. In contrast, platelet aggregation was blocked by antibodies to human C8 (5/7) or C9 (7/7). F(ab’)2 fragments of patient IgG failed to induce platelet activation although they bound to HLA antigen on platelets. Intact patient IgG failed to aggregate washed platelets unless aged serum was added. The activating IgG could be adsorbed by incubation with lymphocytes and eluted from the lymphocytes. These results indicate that complement activation is involved in the aggregation response to HLA-related antibodies. This is the first demonstration of complement-mediated platelet aggregation by clinical samples. Five of the patients developed thrombocytopenia in relationship to blood transfusion and two patients developed acute thromboembolic disease, suggesting that these antibodies and the complement-dependent pathway of platelet aggregation may be of clinical significance.


Blood ◽  
2015 ◽  
Vol 126 (18) ◽  
pp. 2085-2090 ◽  
Author(s):  
Edward M. Conway

Abstract Hemolytic-uremic syndrome (HUS) is a thrombotic microangiopathy that is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. Excess complement activation underlies atypical HUS and is evident in Shiga toxin–induced HUS (STEC-HUS). This Spotlight focuses on new knowledge of the role of Escherichia coli–derived toxins and polyphosphate in modulating complement and coagulation, and how they affect disease progression and response to treatment. Such new insights may impact on current and future choices of therapies for STEC-HUS.


Author(s):  
Ting Gao ◽  
Mingdong Hu ◽  
Xiaopeng Zhang ◽  
Hongzhen Li ◽  
Lin Zhu ◽  
...  

AbstractAn excessive immune response contributes to SARS-CoV, MERS-CoV and SARS-CoV-2 pathogenesis and lethality, but the mechanism remains unclear. In this study, the N proteins of SARS-CoV, MERS-CoV and SARS-CoV-2 were found to bind to MASP-2, the key serine protease in the lectin pathway of complement activation, resulting in aberrant complement activation and aggravated inflammatory lung injury. Either blocking the N protein:MASP-2 interaction or suppressing complement activation can significantly alleviate N protein-induced complement hyper-activation and lung injury in vitro and in vivo. Complement hyper-activation was also observed in COVID-19 patients, and a promising suppressive effect was observed when the deteriorating patients were treated with anti-C5a monoclonal antibody. Complement suppression may represent a common therapeutic approach for pneumonia induced by these highly pathogenic coronaviruses.One Sentence SummaryThe lectin pathway of complement activation is a promising target for the treatment of highly pathogenic coronavirus induced pneumonia.


2019 ◽  
Vol 317 (5) ◽  
pp. F1293-F1304 ◽  
Author(s):  
Sandhya Xavier ◽  
Ranjit K. Sahu ◽  
Sai Vineela Bontha ◽  
Valeria Mas ◽  
Ronald P. Taylor ◽  
...  

We have previously reported that complement activation precedes the development of kidney fibrosis; however, little is known about the cellular mechanisms involved in this transition. We hypothesized that increased expression of C1 complex protease C1r, the initiator of complement activation, contributes to tubulointerstitial fibrosis and tested this idea in mice with global deletion of C1r. Although expression of C1r in untreated wild-type (WT) mice was higher in the liver compared with kidney tissue, administration of folic acid (FA) led to upregulation of C1r mRNA and protein levels only in kidney tissue. Immunohistochemistry and in situ hybridization experiments localized increased expression of C1r and C1s proteases to renal tubular epithelial cells. C1r-null mice had reduced acute tubular injury and inflammation measured 2 days after FA administration compared with WT mice. C1r deletion reduced expression of C1s, C3 fragment formation, and organ fibrosis measured 14 days after FA administration. Differential gene expression performed in kidney tissue demonstrated that C1r-null mice had reduced expression of genes associated with the acute phase response, complement, proliferation of connective tissue cells (e.g., platelet-derived growth factor receptor-β), and reduced expression of genes associated with inflammation compared with FA-treated WT mice. In vitro experiments in renal epithelial cells demonstrated that C1s expression is dependent on increased C1r expression and that interferon-γ induces the expression of these two proteases. We conclude that increased expression of C1 complex proteases is associated with increased tissue inflammation and complement C3 formation and represents an important pathogenic mechanism leading to FA-mediated tubulointerstitial fibrosis.


2019 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
Lateb Maël ◽  
Christine Payre ◽  
Brglez Vesna ◽  
Vincent L M Esnault ◽  
Gérard Lambeau ◽  
...  

1981 ◽  
Vol 4 (4) ◽  
pp. 174-177 ◽  
Author(s):  
H. Wysocki ◽  
R. Czarnecki ◽  
B. Wierusz-Wysocka ◽  
A. Wykrȩtowicz ◽  
K. Wysocki ◽  
...  

The intracellular lysozyme and beta-glucuronidase contents were estimated in PMN isolated from peripheral blood before HD and those from the first portion of full blood leaving the dialyser. The lysozyme estimations were done by the use of the turbidimetric method and beta-glucouronidase was assayed by measuring the release of phenolphtalein from its beta-glucuronate. The cells leaving the cellophane dialyser showed the significantly decreased lysozyme contents while the estimated intracellular activity of beta-glucuronidase was practically equal in both evaluated samples. The results seem to indicate that the HD-associated complement activation may result not only from the simple plasma-cellophane ineteraction. The direct cleavage of the inactive C5 complement component by products released from the PMN specific granules seems to play an important role too. For several years it has been known that the hemodialysis (HD)-induced granulopenia is the result of the pulmonary polymorphonuclear neutrophils (PMN) sequestration (Toren et al., 1970). Recent studies have established that this phenomenon is the consequence of complement activation leading to PMN aggregation with subsequent pulmonary vascular embolization and/or PMN adherence to endothelial surface (Craddock et al. 1977a, Craddock et al., 1979). It was also observed that the contact of patients plasma or plasma obtained from experimental animals with dialyser cellophane results, both in vitro and during HD, in the appearance of the activities: inducing the PMN aggregation, chemotactic and augmenting the PMN adherence (Craddock et al. 1977b, Wysocki et al. 1980). At least the two first are identified as related to the presence of the C5a complement component (Craddock et al., 1977b, O'Flaherty et al., 1979). Similarly, the disseminated complement activation appears to be the main reason of granulopenia accompanying the filtration leukapheresis (FL), the procedure suitable for PMN collection from donors peripheral blood (Hammerschmidt et al., 1978). The PMN are there sequestered in nylon wool layer and subsequently eluted for transfusion purposes. The exposition of blood to artificial surface leads there, like during HD, to the complement (C5) activation. Although, as reported by Wright et al.) 1978b), when plasma and leukocyte enriched blood were diverted by a cell separator before passage through nylon wool filters during FL, complement activation was evident only in plasma from blood containing leukocytes, indicating that extracorporeal complement activation during FL is dependent in large part upon the interaction of leukocytes with nylon wool. The more precise studies of these authors (Wright et al., 1978a) may imply, that the PMN granule constituents released after the previous adherence of cells to nylon fibers are responsible for the FL-associated complement activation. The following studies were done in order to evaluate if the PMN degranulation may take part also in complement activation during hemodialysis carried out with the use of cellophane equipment.


2020 ◽  
Vol 21 (5) ◽  
pp. 1693 ◽  
Author(s):  
Chao Huang ◽  
Kiera P. Fisher ◽  
Sandra S. Hammer ◽  
Julia V. Busik

Several studies have suggested that there is a link between membrane attack complex (MAC) deposition in the retina and the progression of diabetic retinopathy (DR). Our recent investigation demonstrated that circulating IgG-laden extracellular vesicles contribute to an increase in retinal vascular permeability in DR through activation of the complement system. However, the mechanism through which extracellular vesicle-induced complement activation contributes to retinal vascular cytolytic damage in DR is not well understood. In this study, we demonstrate that IgG-laden extracellular vesicles in rat plasma activate the classical complement pathway, and in vitro Streptozotocin (STZ)-induced rat diabetic plasma results in MAC deposition and cytolytic damage in human retinal endothelial cells (HRECs). Moreover, removal of the plasma extracellular vesicles reduced the MAC deposition and abrogated cytolytic damage seen in HRECs. Together, the results of this study demonstrate that complement activation by IgG-laden extracellular vesicles in plasma could lead to MAC deposition and contribute to endothelium damage and progression of DR.


Sign in / Sign up

Export Citation Format

Share Document